OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
Jiahui Xu, Shilian Hu, Guodong Shen, et al.
Cancer Cell International (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 70
Jiahui Xu, Shilian Hu, Guodong Shen, et al.
Cancer Cell International (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 70
Showing 1-25 of 70 citing articles:
Regulating tumor suppressor genes: post-translational modifications
Ling Chen, Shuang Liu, Yongguang Tao
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 329
Ling Chen, Shuang Liu, Yongguang Tao
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 329
A Compressive Review about Taxol®: History and Future Challenges
Julia Gallego‐Jara, Gema Lozano Terol, Rosa Alba Sola Martínez, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5986-5986
Open Access | Times Cited: 248
Julia Gallego‐Jara, Gema Lozano Terol, Rosa Alba Sola Martínez, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5986-5986
Open Access | Times Cited: 248
Mechanisms of Taxane Resistance
Sara Maloney, Camden A. Hoover, Lorena V. Morejon-Lasso, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3323-3323
Open Access | Times Cited: 145
Sara Maloney, Camden A. Hoover, Lorena V. Morejon-Lasso, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3323-3323
Open Access | Times Cited: 145
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 113
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 113
Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway
Jiguang Han, Baojuan Han, Xueya Wu, et al.
Toxicology and Applied Pharmacology (2018) Vol. 359, pp. 55-61
Closed Access | Times Cited: 120
Jiguang Han, Baojuan Han, Xueya Wu, et al.
Toxicology and Applied Pharmacology (2018) Vol. 359, pp. 55-61
Closed Access | Times Cited: 120
Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis
Yinghua Li, Min Guo, Zhengfang Lin, et al.
International Journal of Nanomedicine (2016) Vol. Volume 11, pp. 6693-6702
Open Access | Times Cited: 109
Yinghua Li, Min Guo, Zhengfang Lin, et al.
International Journal of Nanomedicine (2016) Vol. Volume 11, pp. 6693-6702
Open Access | Times Cited: 109
Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
Wenrui Wang, Lingyu Zhang, Yangyang Wang, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 10, pp. e3071-e3071
Open Access | Times Cited: 107
Wenrui Wang, Lingyu Zhang, Yangyang Wang, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 10, pp. e3071-e3071
Open Access | Times Cited: 107
Enhancing the Activity of Drugs by Conjugation to Organometallic Fragments
Prinessa Chellan, Peter J. Sadler
Chemistry - A European Journal (2020) Vol. 26, Iss. 40, pp. 8676-8688
Open Access | Times Cited: 104
Prinessa Chellan, Peter J. Sadler
Chemistry - A European Journal (2020) Vol. 26, Iss. 40, pp. 8676-8688
Open Access | Times Cited: 104
CircRNAs in anticancer drug resistance: recent advances and future potential
Tianwei Xu, Mengwei Wang, Lihua Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 92
Tianwei Xu, Mengwei Wang, Lihua Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 92
Potential roles and prognostic significance of exosomes in cancer drug resistance
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 70
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 70
Light‐Driven Cascade Mitochondria‐to‐Nucleus Photosensitization in Cancer Cell Ablation
Kang‐Nan Wang, Liu‐Yi Liu, Guobin Qi, et al.
Advanced Science (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 58
Kang‐Nan Wang, Liu‐Yi Liu, Guobin Qi, et al.
Advanced Science (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 58
Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers
Dhanasekhar Reddy, Ranjith Kumavath, Tuan Zea Tan, et al.
Life Sciences (2019) Vol. 241, pp. 117147-117147
Closed Access | Times Cited: 56
Dhanasekhar Reddy, Ranjith Kumavath, Tuan Zea Tan, et al.
Life Sciences (2019) Vol. 241, pp. 117147-117147
Closed Access | Times Cited: 56
Identification of a mechanogenetic link between substrate stiffness and chemotherapeutic response in breast cancer
Scott H. Medina, Brian Bush, Maggie Cam, et al.
Biomaterials (2019) Vol. 202, pp. 1-11
Open Access | Times Cited: 55
Scott H. Medina, Brian Bush, Maggie Cam, et al.
Biomaterials (2019) Vol. 202, pp. 1-11
Open Access | Times Cited: 55
Resveratrol-Loaded TPGS-Resveratrol-Solid Lipid Nanoparticles for Multidrug-Resistant Therapy of Breast Cancer: In Vivo and In Vitro Study
Wenrui Wang, Mengyang Zhou, Xu Yang, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 43
Wenrui Wang, Mengyang Zhou, Xu Yang, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 43
The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer
Pingting Ye, Lei Feng, Shuo Shi, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2101-2101
Open Access | Times Cited: 35
Pingting Ye, Lei Feng, Shuo Shi, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2101-2101
Open Access | Times Cited: 35
Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer
Ting Zhang, Jingwen Luo, Yao Fu, et al.
Colloids and Surfaces B Biointerfaces (2016) Vol. 150, pp. 89-97
Closed Access | Times Cited: 48
Ting Zhang, Jingwen Luo, Yao Fu, et al.
Colloids and Surfaces B Biointerfaces (2016) Vol. 150, pp. 89-97
Closed Access | Times Cited: 48
Alkaloids from Piper nigrum Synergistically Enhanced the Effect of Paclitaxel against Paclitaxel-Resistant Cervical Cancer Cells through the Downregulation of Mcl-1
Zhoufan Xie, Yulu Wei, Jie Xu, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 18, pp. 5159-5168
Closed Access | Times Cited: 48
Zhoufan Xie, Yulu Wei, Jie Xu, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 18, pp. 5159-5168
Closed Access | Times Cited: 48
A subcomponent-guided deep learning method for interpretable cancer drug response prediction
Xuan Liu, Wen Zhang
PLoS Computational Biology (2023) Vol. 19, Iss. 8, pp. e1011382-e1011382
Open Access | Times Cited: 15
Xuan Liu, Wen Zhang
PLoS Computational Biology (2023) Vol. 19, Iss. 8, pp. e1011382-e1011382
Open Access | Times Cited: 15
Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells
Lingfeng He, Huan Yang, Shiying Zhou, et al.
DNA repair (2018) Vol. 63, pp. 1-9
Closed Access | Times Cited: 39
Lingfeng He, Huan Yang, Shiying Zhou, et al.
DNA repair (2018) Vol. 63, pp. 1-9
Closed Access | Times Cited: 39
Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway
Leichao Liu, Ti Meng, Xiaowei Zheng, et al.
Molecular Cancer Therapeutics (2019) Vol. 18, Iss. 12, pp. 2457-2468
Open Access | Times Cited: 36
Leichao Liu, Ti Meng, Xiaowei Zheng, et al.
Molecular Cancer Therapeutics (2019) Vol. 18, Iss. 12, pp. 2457-2468
Open Access | Times Cited: 36
Gold nanoparticle‑mediated delivery of paclitaxel and nucleic acids for cancer therapy (Review)
Zhiguang Wang, Jianyu Dong, Qiaojiajie Zhao, et al.
Molecular Medicine Reports (2020) Vol. 22, Iss. 6, pp. 4475-4484
Open Access | Times Cited: 33
Zhiguang Wang, Jianyu Dong, Qiaojiajie Zhao, et al.
Molecular Medicine Reports (2020) Vol. 22, Iss. 6, pp. 4475-4484
Open Access | Times Cited: 33
Polo-Like Kinase 2: From Principle to Practice
Chuanyong Zhang, Chuangye Ni, Hao Lu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Chuanyong Zhang, Chuangye Ni, Hao Lu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
Casey D. Stefanski, Jenifer R. Prosperi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7844-7844
Open Access | Times Cited: 32
Casey D. Stefanski, Jenifer R. Prosperi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7844-7844
Open Access | Times Cited: 32
A potential tumor suppressor role of PLK 2 in glioblastoma
Xiangping Xia, Peirui Wang, Hua Xiao, et al.
FEBS Open Bio (2025)
Open Access
Xiangping Xia, Peirui Wang, Hua Xiao, et al.
FEBS Open Bio (2025)
Open Access
Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells
Weibin Wu, Jieyi Ma, Nan Shao, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169229-e0169229
Open Access | Times Cited: 29
Weibin Wu, Jieyi Ma, Nan Shao, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169229-e0169229
Open Access | Times Cited: 29
